Texas Permanent School Fund raised its holdings in shares of Heska Co. (NASDAQ:HSKA – Get Rating) by 2.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,800 shares of the medical research company’s stock after purchasing an additional 206 shares during the quarter. Texas Permanent School Fund’s holdings in Heska were worth $737,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in HSKA. Truist Financial Corp lifted its position in shares of Heska by 13.2% during the first quarter. Truist Financial Corp now owns 4,202 shares of the medical research company’s stock worth $581,000 after purchasing an additional 489 shares during the last quarter. abrdn plc lifted its position in shares of Heska by 0.9% during the first quarter. abrdn plc now owns 330,796 shares of the medical research company’s stock worth $45,742,000 after purchasing an additional 2,976 shares during the last quarter. Envestnet Asset Management Inc. lifted its position in shares of Heska by 18.3% during the first quarter. Envestnet Asset Management Inc. now owns 11,326 shares of the medical research company’s stock worth $1,566,000 after purchasing an additional 1,752 shares during the last quarter. State Board of Administration of Florida Retirement System lifted its position in shares of Heska by 45.4% during the first quarter. State Board of Administration of Florida Retirement System now owns 3,781 shares of the medical research company’s stock worth $523,000 after purchasing an additional 1,180 shares during the last quarter. Finally, Monarch Partners Asset Management LLC bought a new stake in shares of Heska during the first quarter worth $1,549,000. 97.39% of the stock is currently owned by institutional investors.
Heska Price Performance
HSKA opened at $64.00 on Monday. The business’s 50-day moving average is $73.80 and its two-hundred day moving average is $85.55. Heska Co. has a 1 year low of $58.00 and a 1 year high of $189.37. The company has a debt-to-equity ratio of 0.24, a current ratio of 7.18 and a quick ratio of 5.61. The firm has a market capitalization of $692.86 million, a PE ratio of -40.76 and a beta of 1.45.
Analyst Upgrades and Downgrades
Heska Company Profile
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers.
- Get a free copy of the StockNews.com research report on Heska (HSKA)
- Is GameStop Stock Setting Up for Another Short Squeeze?
- Here’s Why SoFi Technologies Stock is Cheap at These Levels
- Warren Buffet Bought Taiwan Semiconductor Stock, Should You?
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.